Strategies and methods for implementing successful adaptive design studies

Jan. 10, 2012 - PRLog -- SMI is proud to present the 6th annual conference…
Adaptive Designs in Clinical Drug Development
‘Buying in’ to adaptive design trials: strategies and methods for
implementing successful adaptive design studies

26-27 March 2012, Grange Holborn, London

http://www.smi-online.co.uk/2012adaptivedesigns16.asp
This conference will address and explore key issues such as current technologies, dose finding, adaptive clinical trials for rare disease medicine development, Bayesian adaptive designs, high-density biomarker data and adaptive designs versus conventional trials. Learn how to maximise efficiency and profitability from case study examples and expert presentations.

This year, the conference will not only tackle issues surrounding effective management of your adaptive design in clinical trials but the increasing use of Bayesian modelling and using adaptive designs in early clinical trials. As adaptive designs are recently gradually evolving from a novel idea into a standard norm in the pharmaceuticals industry, industry leaders are asking themselves whether to adapt or not to adapt.

Hear from key presentations including:
•Adaptive designs so far: how far have we come?
Come and listen to Giacomo Mordenti, Senior Expert Biostatistician, Merck Serono and gain an insight into Bayesian adaptive designs

•Adaptive clinical trials for rare disease medicine development.
A key presentation given by Graeme Archer, Director, Quantitative Sciences – Clinical Statistics, GlaxoSmithKline

Key Speakers line up includes;
•Loic Darchy, Senior Statistician, Sanofi-Aventis
•Giacomo Mordenti, Senior Expert Biostatistician, Merck Serono
•Markus Niggli, Project Statistician & Annette Sauter, Project Statistician, Roche
•Robert Clay, Vice President Regulatory Affairs, Oncology and Infection, AstraZeneca
•Prof Christopher Jennison, Professor of Statistics, University of Bath
•Graeme Archer, Director, Quantitative Sciences – Clinical Statistics, GlaxoSmithKline
•Frank Fleischer, Teamleader Clinical Biostatistics, Boehringer Ingelheim
•Yu Shyr, Professor, Cancer Biostatistics, Vanderbilt University

Visit our website for full details:
http://www.smi-online.co.uk/2012adaptivedesigns16.asp

Alternatively contact Shilan Chandi on +44 (0) 20 7827 6738
or e-mail: schandi@smi-online.co.uk